A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with

G Orgiana1, G Pinna, A Camedda

  • 1Division of Endocrinology, University of Cagliari, 09042 Monserrato-Cagliari, Italy.

Insights

A novel RET gene mutation, R694Q, was identified in individuals without Multiple Endocrine Neoplasia (MEN) or Familial Medullary Thyroid Carcinoma (FMTC). Functional studies confirmed this mutation lacks oncogenic activity, highlighting challenges in RET gene research.

Area of Science:

  • Genetics
  • Oncology
  • Endocrinology

Background:

  • Gain-of-function RET mutations cause MEN 2A/2B and FMTC.
  • Loss-of-function RET mutations are linked to Hirschsprung disease.
  • The RET proto-oncogene plays a critical role in neuroendocrine development and tumorigenesis.

Observation:

  • A novel RET point mutation, R694Q, was incidentally discovered in a young woman with hypothyroidism and ovarian failure.
  • The mutation was inherited from her mother, who had Hashimoto's thyroiditis but no history of MEN or FMTC.
  • Extensive familial screening revealed no clinical or biochemical evidence of MEN syndromes or Hirschsprung disease.

Findings:

  • In vitro studies demonstrated that the R694Q RET mutant exhibited no significant potentiation of RET kinase activity.
  • Focus assays in NIH3T3 fibroblasts showed the R694Q mutant lacked significant transforming activity.
  • These functional assays confirmed the lack of activating potential for the novel RET mutation.

Implications:

  • This discovery identifies a new RET mutation in individuals without associated endocrine neoplasia syndromes.
  • The findings underscore the complexity of RET mutations and their variable clinical penetrance.
  • It highlights potential challenges in interpreting incidental genetic findings within the context of genomic screening programs.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...